Gary T. Ferguson

17.3k total citations · 4 hit papers
188 papers, 11.4k citations indexed

About

Gary T. Ferguson is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Gary T. Ferguson has authored 188 papers receiving a total of 11.4k indexed citations (citations by other indexed papers that have themselves been cited), including 167 papers in Pulmonary and Respiratory Medicine, 107 papers in Physiology and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Gary T. Ferguson's work include Chronic Obstructive Pulmonary Disease (COPD) Research (144 papers), Asthma and respiratory diseases (102 papers) and Inhalation and Respiratory Drug Delivery (71 papers). Gary T. Ferguson is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (144 papers), Asthma and respiratory diseases (102 papers) and Inhalation and Respiratory Drug Delivery (71 papers). Gary T. Ferguson collaborates with scholars based in United States, United Kingdom and Germany. Gary T. Ferguson's co-authors include Christine Jenkins, Jørgen Vestbo, Bartolomé R. Celli, Julie A. Anderson, Julie Yates, Paul Jones, Peter Calverley, Reuben M. Cherniack, Peter M.A. Calverley and Colin Reisner and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Gary T. Ferguson

183 papers receiving 11.0k citations

Hit Papers

Salmeterol and Fluticasone Propionate and Survival in Chr... 2007 2026 2013 2019 2007 2016 2008 2020 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
    2007 2.3k citations Julie A. Anderson, Bartolomé R. Celli et al. profile →
  2. Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial
    2016 984 citations Gary T. Ferguson, Magnus Aurivillius et al. profile →
  3. Effect of Pharmacotherapy on Rate of Decline of Lung Function in Chronic Obstructive Pulmonary Disease: Results from the TORCH Study
    2008 541 citations Bartolomé R. Celli, Julie A. Anderson et al. American Journal of Respiratory and Critical Care Medicine profile →
  4. Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD
    2020 374 citations Klaus F. Rabe, Gary T. Ferguson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary T. Ferguson United States 40 10.1k 7.1k 576 543 500 188 11.4k
Sidney S. Braman United States 31 5.2k 0.5× 3.9k 0.6× 652 1.1× 563 1.0× 513 1.0× 93 7.3k
Lisa Edwards United States 39 6.4k 0.6× 3.5k 0.5× 509 0.9× 275 0.5× 408 0.8× 113 7.5k
Sonia Buist United States 24 6.0k 0.6× 2.8k 0.4× 655 1.1× 240 0.4× 628 1.3× 44 7.4k
Κonstantinos Κostikas Greece 44 4.4k 0.4× 3.2k 0.5× 473 0.8× 321 0.6× 283 0.6× 287 6.5k
Courtney Crim United States 40 7.0k 0.7× 3.5k 0.5× 599 1.0× 283 0.5× 315 0.6× 123 7.9k
Jinping Zheng China 25 5.0k 0.5× 2.6k 0.4× 539 0.9× 406 0.7× 419 0.8× 162 6.4k
Vanessa M. McDonald Australia 43 4.1k 0.4× 3.7k 0.5× 390 0.7× 305 0.6× 400 0.8× 213 5.8k
Henrik Watz Germany 41 5.9k 0.6× 3.3k 0.5× 444 0.8× 230 0.4× 294 0.6× 188 7.3k
Neil Barnes United Kingdom 51 6.8k 0.7× 6.8k 1.0× 439 0.8× 661 1.2× 857 1.7× 180 9.4k
Chin Kook Rhee South Korea 35 3.3k 0.3× 1.9k 0.3× 662 1.1× 438 0.8× 356 0.7× 332 5.2k

Countries citing papers authored by Gary T. Ferguson

Since Specialization
Citations

This map shows the geographic impact of Gary T. Ferguson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary T. Ferguson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary T. Ferguson more than expected).

Fields of papers citing papers by Gary T. Ferguson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary T. Ferguson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary T. Ferguson. The network helps show where Gary T. Ferguson may publish in the future.

Co-authorship network of co-authors of Gary T. Ferguson

This figure shows the co-authorship network connecting the top 25 collaborators of Gary T. Ferguson. A scholar is included among the top collaborators of Gary T. Ferguson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary T. Ferguson. Gary T. Ferguson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sethi, Sanjay, Swetha Palli, Lindsay G.S. Bengtson, et al.. (2023). Clinical and economic outcomes in patients with chronic obstructive pulmonary disease initiating maintenance therapy with tiotropium bromide/olodaterol or fluticasone furoate/umeclidinium/vilanterol. Journal of Managed Care & Specialty Pharmacy. 29(7). 791–806. 4 indexed citations
2.
Ohar, Jill, Gary T. Ferguson, Donald A. Mahler, et al.. (2022). Measuring Peak Inspiratory Flow in Patients with Chronic Obstructive Pulmonary Disease. International Journal of COPD. Volume 17. 79–92. 20 indexed citations
3.
Martínez, Fernando J., Gary T. Ferguson, Eric Bourne, et al.. (2021). Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Exacerbation Outcomes in Patients with COPD without a Recent Exacerbation History: A Subgroup Analysis of KRONOS. International Journal of COPD. Volume 16. 179–189. 11 indexed citations
4.
Ferguson, Gary T., Tor Skärby, Lars H. Nordenmark, et al.. (2020). <p>Unreported and Overlooked: A Post Hoc Analysis of COPD Symptom-Related Attacks from the RISE Study</p>. International Journal of COPD. Volume 15. 3123–3134. 3 indexed citations
5.
Ferguson, Gary T., et al.. (2020). <p>Effect of Inhaled Corticosteroid Withdrawal on Chronic Obstructive Pulmonary Disease Exacerbations in Patients Taking Triple Therapy at Baseline</p>. International Journal of COPD. Volume 15. 2879–2888. 4 indexed citations
6.
7.
Martínez, Fernando J., Klaus F. Rabe, Gary T. Ferguson, et al.. (2020). Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for Chronic Obstructive Pulmonary Disease. A Randomized, Double-Blind, Multicenter, Parallel-Group Study. American Journal of Respiratory and Critical Care Medicine. 203(5). 553–564. 147 indexed citations
8.
Ichinose, Masakazu, Yasushi Fukushima, Yoshikazu Inoue, et al.. (2019). <p>Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD: A Subgroup Analysis of the KRONOS Study</p>. International Journal of COPD. Volume 14. 2979–2991. 12 indexed citations
9.
Martínez, Fernando J., R Abrahams, Gary T. Ferguson, et al.. (2019). Effects of baseline symptom burden on treatment response in COPD. International Journal of COPD. Volume 14. 181–194. 8 indexed citations
10.
Ichinose, Masakazu, Yasushi Fukushima, Yoshikazu Inoue, et al.. (2019). <p>Long-Term Safety and Efficacy of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD</p>. International Journal of COPD. Volume 14. 2993–3002. 14 indexed citations
11.
12.
Ferguson, Gary T., et al.. (2017). In Vitro Characterization of the eFlow Closed System Nebulizer with Glycopyrrolate Inhalation Solution. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 31(3). 162–169. 24 indexed citations
13.
Abrahams, R, Gary T. Ferguson, Emmanuelle Clerisme-Beaty, et al.. (2015). Effect of Tiotropium + Olodaterol on the Use of Nighttime Rescue Medication in Patients With COPD: Results From Four Randomized, Double-Blind Studies. CHEST Journal. 148(4). 731A–731A. 1 indexed citations
14.
Buhl, Roland, Eric Derom, Gary T. Ferguson, et al.. (2014). Once-daily tiotropium and olodaterol fixed-dose combination via the respimat improves outcomes vs mono-components in COPD in two 1-year studies. European Respiratory Journal. 44(Suppl 58). 1895–1895. 2 indexed citations
15.
Keene, Oliver N., Jørgen Vestbo, Julie A. Anderson, et al.. (2009). Methods for therapeutic trials in COPD: lessons from the TORCH trial. European Respiratory Journal. 34(5). 1018–1023. 22 indexed citations
16.
Crim, Courtney, Peter Calverley, Julie A. Anderson, et al.. (2009). Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results. European Respiratory Journal. 34(3). 641–647. 319 indexed citations
17.
Ferguson, Gary T.. (2009). L'homme en tous genres : masculinités, textes et contextes. L'Harmattan eBooks. 1 indexed citations
18.
Ferguson, Gary T., et al.. (1998). Improved Exercise Performance Following Lung Volume Reduction Surgery for Emphysema. American Journal of Respiratory and Critical Care Medicine. 157(4). 1195–1203. 54 indexed citations
19.
Bailey, William C., Gary T. Ferguson, Millicent Higgins, et al.. (1998). Strategies in preserving lung health and preventing COPD and associated diseases: The National Lung Health Education Program (NLHEP). CHEST Journal. 113. 38 indexed citations
20.
Snyder, Donald L. & Gary T. Ferguson. (1994). Cost of Community Services Study Cache, Sevier, and Utah Counties. Digital Commons - USU (Utah State University). 94(19). 1–169. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sidney S. Braman Breakdown of academic impact, for papers by Lisa Edwards Breakdown of academic impact, for papers by Sonia Buist Breakdown of academic impact, for papers by Κonstantinos Κostikas Breakdown of academic impact, for papers by Courtney Crim Breakdown of academic impact, for papers by Jinping Zheng Breakdown of academic impact, for papers by Vanessa M. McDonald Breakdown of academic impact, for papers by Henrik Watz Breakdown of academic impact, for papers by Neil Barnes Breakdown of academic impact, for papers by Chin Kook Rhee
Rankless by CCL
2026